Combination products are complex by definition, and the product development cycles can be both time- and resource-intensive. The common theme of challenges has been formulation …
There’s an important person out there influencing your next oncology trial patient. We don’t often talk about this person within clinical research, much less plan …
Study oversight is a broad topic. We have reviewed how site performance and clinical data controls can be implemented across various monitoring techniques as well …
Big data combined with advances in data science approaches have provided a valuable opportunity for the pharma industry to uncover previously unobtainable insight that has …
Six simple but effective steps to set the TMF in the right direction The clinical trial master file (TMF) is a bit of a misnomer, …
By reducing enterprise systems into three key services of data management, information security and data access, we can solve many of the current challenges faced …
Tablet compression tools are often viewed as consumable items; therefore, maintenance can be seen as unnecessary and time-consuming. This can be a costly mistake and …
The development of a dissolution method with suitable specifications is a key part of any oral drug product control strategy. Dissolution testing is an in …
Ophthalmic pathologies include eyesight-threatening conditions (diabetic retinopathy, glaucoma, cataract, age-related macular degeneration and retinal detachment) and, relatively speaking, less serious eye conditions (dry eye, red …
Way back prior to 2016, Brussels Airport, Miami International Airport and Singapore Changi Airport came together with the joint ambition of fostering greater collaboration amongst …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative